On Tuesday, Juno Therapeutics Inc (NASDAQ:JUNO)’s shares inclined 2.08% to $35.81.
Juno Therapeutics Inc (JUNO) might not be turning a profit yet, but that’s no problem for CEO Hans Bishop’s personal bottom line.
Bishop is the 11th highest-paid CEO in the country, according to Bloomberg’s Pay Index, a daily ranking of the 100 top-paid executives. His pay package was worth $88.2 million at the end of 2014, Bloomberg stated Thursday, in a combination of salary, stock options and restricted shares. That was worth $7.3 million before Juno’s initial public offering in December.
Juno isn’t the only biotech to show up near the top of the list. CEO pay at Santa Monica, Calif.-based Kite Pharma and Waltham, Mass.-based Radius Health Inc. topped $95 million and $33.5 million, respectively.
Juno and Kite develop immunotherapy treatments for cancer. That’s a field investors have been excited to jump into in recent years. Immunotherapy reprograms a patient’s T cells and then infuses them back into the body, giving the immune system a boost to battle the cancer.
This treatment has been heralded in recent years as a breakthrough alternative to harsher methods, such as chemotherapy and radiation.
In small clinical trials, one of Juno’s drug candidates has achieved a 90 percent remission rate in a type of blood cancer.
Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell-based cancer immunotherapies. The company develops cell-based cancer immunotherapies based on its chimeric antigen receptor and T cell receptor technologies to genetically engineer T cells to recognize and kill cancer cells.
KAR Auction Services Inc (NYSE:KAR)’s shares dropped -1.00% to $35.74.
Insurance Auto Auctions, Inc. (IAA), a business unit of KAR Auction Services (KAR), and the leading live and live-online salvage auto auction company, recently declared the recent expansion of its Austin branch. The facility, now comprising 57 acres, offers IAA buyers and sellers an improved auction experience.
IAA relocated its Austin branch in July 2012 to the current location, which initially spanned 37 acres and featured two covered run-and-drive lanes and 250 feet of covered motorcycle and high-value vehicle storage area. The recent expansion of 20 acres, accomplished this month, gives IAA more versatility in providing quality service and raised production to a higher volume of customers.
IAA’s unmatched operational expertise assists to provide end-to-end solutions and standardized quality assurance practices. IAA buyers have access via their mobile devices and can bid on up to eight auctions at a time. The IAA Auction Center offers auctions in six languages counting: English, Spanish, Mandarin Chinese, French, Polish and Russian. An estimated 30 percent of IAA’s vehicles are sold and exported to foreign countries, which further strengthens its philosophy of choice and flexibility with “anywhere” access and mobile technology.
KAR Auction Services, Inc., together with its auxiliaries, provides vehicle auction services in North America. It operates in three segments: ADESA Auctions, IAA, and AFC. The ADESA Auctions segment offers whole car auctions and related services to the vehicle remarketing industry through online auctions and auction facilities. It also provides value-added services, such as auction related, transportation, reconditioning, inspection, title and repossession administration and remarketing, and analytical services. This segment sells its products and services through vehicle manufacturers, rental car companies, and finance companies.
At the end of Tuesday’s trade, Cincinnati Financial Corporation (NASDAQ:CINF)‘s shares dipped -0.70% to $50.91.
Cincinnati Financial Corporation (CINF) declared that, at regular meeting, the board of directors declared a 46-cents-per-share regular quarterly cash dividend. The dividend is payable October 15, 2015, to shareholders of record as of September 16, 2015.
Cincinnati Financial Corporation engages in the property casualty insurance business in the United States. It operates in five segments: Commercial Lines Insurance, Personal Lines Insurance, Excess and Surplus Lines Insurance, Life Insurance, and Investments. The Commercial Lines Insurance segment provides coverage for commercial casualty, commercial property, commercial auto, and workers compensation. This segment also offers director and officer liability insurance, contract and commercial surety bonds, and fidelity bonds; and machinery and equipment coverage, in addition to coverage for property, liability, and business interruption.
Amedica Corporation (NASDAQ:AMDA), ended its Tuesday’s trading session with 5.05% gain, and closed at $0.435.
Amedica Corporation (AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, declared that responses to the U.S. Food and Drug Administration (“FDA”) inquiries regarding the Company’s cervical composite silicon nitride interbody device were presented to the FDA on June 30, 2015. Additionally, the Company has received feedback from the FDA regarding its wear testing femoral head protocols.
Submission for 510(k) clearance of the Valeo C Interbody with CsC Osteo-Conductive Scaffolding (“Valeo C CsC”), which was presented in the first quarter of 2015, relates to the Company’s CASCADE clinical trial of its composite silicon nitride spinal interbody devices. Since submission, the Company received a list of questions from the FDA requesting additional information pertaining to the product’s clinical performance data, in addition to indications for use and device description. The Company has responded to the questions and now awaits clearance of the Class II medical device for commercial distribution or additional communication from the FDA.
Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. It offers Valeo silicon nitride interbody spinal fusion devices for use in the cervical and thoracolumbar areas of the spine; and a line of non-silicon nitride spinal fusion products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
